Swiss National Bank Decreases Holdings in Amedisys, Inc. (NASDAQ:AMED)

Swiss National Bank decreased its position in Amedisys, Inc. (NASDAQ:AMED) by 0.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,800 shares of the health services provider’s stock after selling 600 shares during the quarter. Swiss National Bank’s holdings in Amedisys were worth $6,157,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Alpine Associates Management Inc. increased its holdings in Amedisys by 0.9% during the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock valued at $117,586,000 after buying an additional 11,000 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after acquiring an additional 19,660 shares during the last quarter. Calamos Advisors LLC grew its position in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after acquiring an additional 41,220 shares during the period. Highbridge Capital Management LLC increased its stake in shares of Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after purchasing an additional 83,200 shares in the last quarter. Finally, SG Americas Securities LLC raised its holdings in Amedisys by 413.4% in the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after purchasing an additional 158,398 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Performance

NASDAQ:AMED opened at $91.02 on Wednesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a 50-day simple moving average of $95.22 and a two-hundred day simple moving average of $95.74. The firm has a market capitalization of $2.98 billion, a PE ratio of 36.12, a P/E/G ratio of 1.90 and a beta of 0.78. Amedisys, Inc. has a 52-week low of $88.81 and a 52-week high of $98.95.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same quarter last year, the firm posted $0.98 earnings per share. The company’s revenue was up 5.7% compared to the same quarter last year. Analysts forecast that Amedisys, Inc. will post 4.55 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.